MADE in America Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The MADE in America Act (H.R. 2707) is a bill introduced in the 118th Congress aimed at promoting the use of American-made products in health-related sectors. While the official summary and full text of the bill are not available, the bill's title and policy area suggest a focus on encouraging domestic manufacturing and procurement within health programs or agencies. The bill was referred to the Subcommittee on Health but ultimately failed or expired without further legislative action.
H.R. 2707 sought to enhance the use of American-made products in health-related contexts but did not advance beyond subcommittee referral and expired in the 118th Congress.
- The bill is titled the MADE in America Act and relates to the health policy area.
- It was introduced in the House and referred to the Subcommittee on Health on December 17, 2024.
- The bill did not progress beyond referral and is currently classified as failed or expired.
['American manufacturers and suppliers in the health sector', 'Federal health agencies and programs that may prioritize domestic products', 'Potentially workers and industries involved in domestic production related to health']
['Lack of available full text limits understanding of specific provisions and implementation mechanisms.', 'No information on funding or enforcement provisions is available, which could affect feasibility.', 'Potential trade-offs between promoting domestic products and cost or availability of health-related goods.']
The bill was introduced during the 118th Congress and referred to the House Subcommittee on Health. It did not advance further and expired, indicating limited legislative momentum. The focus on domestic manufacturing aligns with broader policy discussions on supply chain resilience and economic competitiveness in health-related industries.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could encourage increased domestic production in health-related manufacturing, potentially impacting supply chains.', 'Promoting American-made products might influence procurement policies in federal health programs, affecting suppliers and contractors.', 'The focus on domestic sourcing could have economic effects on international trade relationships in health goods.']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's detailed provisions. Additionally, the bill's failure to progress beyond subcommittee referral highlights the importance of tracking legislative movement to assess potential impacts. Future transparency efforts would benefit from ensuring full text availability and timely updates on legislative status.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.